Skip to main content

Table 6 Segmented regression analysis for vascular protective and comparator medication coverage, 2010 to 2016, administrative cohort

From: Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study

Variable

Estimate

SE

Pvalue

STATIN

 Baseline prescription rate

60.99

0.31

<.0001

 Pre-intervention slope

0.20

0.04

<.0001

 Change at guideline (2013Q2)

−0.26

0.39

0.51

 Slope change

− 0.12

0.05

0.04

ACEI or ARB

 Baseline prescription rate

62.16

0.23

<.0001

 Pre-intervention slope

−0.13

0.03

0.0001

 Change at guideline (2013Q2)

0.21

0.29

0.46

 Slope change

0.00

0.04

0.99

Antiplatelet

 Baseline prescription rate

10.46

0.08

<.0001

 Pre-intervention slope

−0.12

0.01

<.0001

 Change at guideline (2013Q2)

−0.09

0.08

0.29

 Slope change

−0.03

0.01

0.03

PPI

 Baseline prescription rate

22.67

0.18

<.0001

 Pre-intervention slope

0.22

0.02

<.0001

 Change at guideline (2013Q2)

0.09

0.21

0.67

 Slope change

−0.11

0.03

0.002